>>> US After Hours Summary: SWBI +16.8% sharply higher on earnings; RUM +6.3% af

After Hours Summary: SWBI +16.8% sharply higher on earnings; RUM +6.3% after closing Northern Data acquisition; STLD -3% lower on guidance

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: SWBI +16.8%,

Companies trading higher in after hours in reaction to news: RUM +6.3% (closes Northern Data acquisition; also introduces new business unit), SPRO +5.7% (FDA approves Utezbi), VRRM +1.9% (organizational changes; appoints new Chief Customer Officer), INOD +1.9% (appoints new CFO; reaffirms FY26 guidance), AXTI +1.7% (unit enters long-term supply agreement with Casela), SPCX +1.1% (elects Roelof Botha as independent Common Stock Director), CLX +1.1% (names new COO and simplifies operating structure), CORT +0.9% (resubmits NDA for Relacorilant as a treatment for patients with Cushing's syndrome), HAWK +0.8% (Cluster 14 satellites have reached full operational capacity), VG +0.7% (new LNG purchase agreements), AAPL +0.4% (Tim Cook says Apple will raise prices due to memory chip crunch, according to WSJ), STN +0.2% (CEO to retire; names next CEO)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: STLD -3% (guidance)

Companies trading lower in after hours in reaction to news: LEGN -8% (ADS offering), NYXH -5.6% (receives $15 mln in proceeds from the European Investment Bank), MX -4.4% (enters at the market sales agreement; may offer up to $50 mln of common stock), SHMD -2.8% (stock offering by selling shareholders), ALKS -0.9% (results from Vibrance-2 Phase 2 Study of Alixorexton in adults with narcolepsy Type 2), GD -0.2% (awarded $116.6 mln modification to previously awarded Navy contract), GSK -0.1% (FDA approves Utezbi), DE -0.1% (files mixed securities shelf offering)